1.41

4.44% 0.06

After Hours: 1.42 0.01 +0.71%

Lucid Diagnostics Inc (LUCD)

Overview News Price History Financials Discussions Forecast

Lucid Diagnostics Inc stock is traded at $1.41, with a volume of 1.63M. It is up +4.44% in the last 24 hours and up +2.92% over the past month. Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Previous Close:

$1.35

Open:

$1.34

24h Volume:

1.63M

Relative Volume:

1.29

Market Cap:

$240.21M

Revenue:

$4.71M

Net Income/Loss:

$-58.01M

P/E Ratio:

-1.7124

EPS:

-0.8234

Net Cash Flow:

$-46.68M

1W Performance:

+25.89%

1M Performance:

+2.92%

6M Performance:

+11.90%

1Y Performance:

+24.78%

1-Day Range:

$1.3201

$1.42

1-Week Range:

$1.125

$1.42

52-Week Range:

$0.9495

$1.70

Lucid Diagnostics Inc Stock (LUCD) Company Profile

Name

Lucid Diagnostics Inc

Sector

Healthcare (1112)

Industry

Medical Devices (143)

Phone

212 949 4319

Address

360 MADISON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-03-26

Latest SEC Filings

LUCD's Discussions on Twitter

Compare LUCD vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LUCD Lucid Diagnostics Inc	1.41	229.99M	4.71M	-58.01M	-46.68M	-0.8234
ABT Abbott Laboratories	101.56	175.59B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	341.24	132.47B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.10	113.14B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	64.61	94.85B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	78.20	45.09B	6.07B	1.06B	1.34B	1.8063

Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-27-21	Initiated	Ascendiant Capital Markets	Buy
Nov-08-21	Initiated	BTIG Research	Buy
Nov-08-21	Initiated	Cantor Fitzgerald	Overweight
Nov-08-21	Initiated	Needham	Buy

Lucid Diagnostics Inc Stock (LUCD) Latest News

Apr 14, 2026

Lucid Diagnostics Outperforms Pressure BioSciences in Key Metrics - National Today

Apr 14, 2026

Apr 13, 2026

Lucid Diagnostics (LUCD) CMO holds 650K shares including restricted stock - Stock Titan

Apr 13, 2026

Layoff Watch: Whats the MACD signal for Lucid Diagnostics Inc2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow

Apr 12, 2026

Apr 11, 2026

Fed Meeting: Is Lucid Diagnostics Inc stock forming a cup and handle2026 PreEarnings & Community Consensus Picks - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Dividend Watch: Can Lucid Diagnostics Inc be recession proofTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 10, 2026

Ascendiant Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Raises Target Price to $9 - Moomoo

Apr 10, 2026

Apr 09, 2026

Breakout Move: What is the next catalyst for Lucid Diagnostics Inc2026 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn

Apr 09, 2026

Lucid Diagnostics to Participate in Needham Healthcare Conference - National Today

Apr 09, 2026

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Bitget

Apr 09, 2026

Lucid Diagnostics to Participate in Fireside Chat at Healthcare Conference - National Today

Apr 09, 2026

Aug Action: Whats the MACD signal for Lucid Diagnostics Inc2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Apr 04, 2026

LUCD PE Ratio & Valuation, Is LUCD Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026